C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2009
10/07/2009	CN101553506A LINGO binding molecules and pharmaceutical use thereof
10/07/2009	CN101553505A Antibodies directed to alphaVbeta6 and uses thereof
10/07/2009	CN101553504A Abeta antibody parenteral formulation
10/07/2009	CN101553503A SHRNA-mediated inhibition of expression of alpha-1,6-fucosyltransferase
10/07/2009	CN101553502A Hemagglutinin polypeptides, and reagents and methods relating thereto
10/07/2009	CN101553501A Il-21变种 Il-21 variant
10/07/2009	CN101553254A Use of TGF-beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia
10/07/2009	CN101553243A Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
10/07/2009	CN101553242A Erythropoietin receptor peptide formulations and uses
10/07/2009	CN101550416A Humanized single anti-Hu-ScFv18 light and heavy chain variable region gene and coding polypeptide thereof and application thereof
10/07/2009	CN101550192A Monoclonal antibody K42-D2 of antihuman granzyme K and hybridoma cell line for excreting same
10/07/2009	CN101550191A Malignant melanoma T cell nano antibody, coding sequence and application thereof
10/07/2009	CN101550190A An anti-il-12 antibody, a composition, a method and the function
10/07/2009	CN101550189A Anthropogenic antivirulin glycosidoprotein neutralizing genetic engineering antibody RD9 and preparation and application thereof
10/07/2009	CN101550188A H5 subtype bird-flue virus H5N1 hemagglutinin monoclonal antibody and nucleic acid sequence and preparation method thereof
10/07/2009	CN101550187A Method for preparing phenothiazine immunizing antigens and antibodies thereof
10/07/2009	CN101550186A Sheep recombination prion protein and monoclonal antibody thereof and application
10/07/2009	CN101549148A Application of polypeptide in preparing the medicine promoting the transformation from endocardium cell to interstitial cell
10/07/2009	CN100547073C Permeases 2,5-DKG
10/07/2009	CN100547003C Antibodies to human IL-1 beta
10/07/2009	CN100546652C Deimmunized monoclonal antibodies for protection against and treating HIV infection
10/07/2009	CN100546651C Method of producing intravenous injection human hepatitis b immune globulin
10/06/2009	USRE40930 Porcine adenovirus type 3 genome
10/06/2009	US7598354 Campylobacter glycans and glycopeptides
10/06/2009	US7598353 Cancer; interferes with the interaction between CD200 and its receptor to block immune suppression thereby promoting eradication of the cancer cells; directly kills the cancer cells either by complement-mediated or antibody-dependent cellular cytotoxicity or by targeting cells using a fusion molecule
10/06/2009	US7598352 Method of identifying polypeptide monobodies which bind to target proteins and use thereof
10/06/2009	US7598351 Monoclonal antibody that specifically binds to a C-terminal partial peptide of the 19P2 ligand or a derivative and a hybridoma cell line that produces it, used for diagnosing hyperprolactinemia
10/06/2009	US7598350 Used in treating neoplastic diseases and hyperproliferative disorders
10/06/2009	US7598349 Antibodies to peptide fragments having cell death-inhibitory activity
10/06/2009	US7598340 Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
10/06/2009	US7598232 Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders
10/06/2009	US7598225 Generation of immune response to prostate-specific antigen (PSA)
10/06/2009	US7598224 Have a hydrophobic linker region and a heparin-binding region, useful as soluble biologics or as surface coatings for medical devices
10/06/2009	US7598081 Materials and procedures for the purification of cells
10/06/2009	US7598052 Expression profile of thyroid cancer
10/06/2009	US7598046 Use of Apolipoprotein B, Apolipoprotein E, fragments for diagnostic, detection, prognostic and therapeutic applications In bovine spongiform encephalopathy (BSE) and Creutzfeld-Jacob Disease
10/06/2009	US7598045 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer
10/06/2009	US7598042 Early prostate cancer antigens (EPCA), polynucleotide sequences encoding them, and their use
10/06/2009	US7597893 Human monoclonal antibody specific lipopolysaccharides (LPS) of serotype IATS 06 of Pseudomonas aeruginosa
10/06/2009	US7597892 Using cytokine specific immunolglobulin as therapeutic in treatment and prevention of skin disorders
10/06/2009	US7597889 Recombinant polypeptides and nucleic acids; Graft-vs-host disease, host-vs-graft disease, organ transplant rejection, bone-marrow transplant rejection, autoimmune vasculitis, arthritis or asthma
10/06/2009	US7597888 nucleic acid molecules and polypeptide molecules that encode glycoprotein VI; modulating agents in regulating a variety of cellular processes
10/06/2009	US7597887 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1)
10/06/2009	US7597886 Tumor necrosis factor-gamma
10/06/2009	CA2376596C Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies
10/06/2009	CA2310888C Monoclonal human natural antibodies
10/06/2009	CA2248543C Directed switch-mediated dna recombination
10/06/2009	CA2218448C Raffinose synthase genes and their use
10/06/2009	CA2207779C Carcinoma treatment
10/06/2009	CA2159106C Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor
10/06/2009	CA2111205C Polypeptides having kinase activity, their preparation and use
10/01/2009	WO2009121004A2 Neutralizing molecules to viral antigens
10/01/2009	WO2009120922A2 Compositions and methods for inhibiting pdgfrbeta and vegf-a
10/01/2009	WO2009120905A2 Immunoglobulin and/or toll-like receptor proteins associated with myelogenous haematological proliferative disorders and uses thereof
10/01/2009	WO2009120903A2 Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
10/01/2009	WO2009120899A2 G coupled protein receptors associated with myelogenous haematological proliferative disorders and uses thereof
10/01/2009	WO2009120769A1 Human anti-mesothelin monoclonal antibodies
10/01/2009	WO2009120684A1 Antibody formulation
10/01/2009	WO2009120651A1 Method to deplete monoclonal antibodies in a biological sample
10/01/2009	WO2009120530A1 Glucagon receptor antagonists
10/01/2009	WO2009119794A1 Prophylactic/therapeutic agent for infectious disease
10/01/2009	WO2009119722A1 Anti-(influenza a virus subtype h5 hemagglutinin) monoclonal antibody
10/01/2009	WO2009119455A1 Cancer cell motility and cancer cell infiltration inhibitor
10/01/2009	WO2009118778A1 Method of separating fish immature germ cell using fish immature germ cell surface-specific protein
10/01/2009	WO2009118660A2 Adam-15 antibodies and immunogenic peptides
10/01/2009	WO2009118300A1 Treating cancer by down-regulating frizzled-4 and/or frizzled-1
10/01/2009	WO2009118273A1 Compositions, methods and kits
10/01/2009	WO2009118142A1 Use of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc) in combination with cyclophosphamide, vincristine and doxorubicine for treating non-hodgkin' s lymphomas
10/01/2009	WO2009117804A1 An anti-cancer cytotoxic monoclonal antibody
10/01/2009	WO2009117773A1 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
10/01/2009	WO2009099961A3 Engineered antibody constant domain molecules
10/01/2009	WO2009095489A3 Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
10/01/2009	WO2009092383A3 Products and methods to prevent infection
10/01/2009	WO2009089535A3 Polypeptide vaccine and vaccination strategy against mycobacterium
10/01/2009	WO2009079259A9 Antibodies against influenza virus and methods of use thereof
10/01/2009	WO2009068627A3 Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
10/01/2009	WO2009015284A3 Il-18 receptor antigen binding proteins
10/01/2009	WO2008103471A9 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease
10/01/2009	WO2008093280A8 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen
10/01/2009	WO2005067620A9 ANTIBODIES TO MAdCAM
10/01/2009	WO2002074916A9 Reg-like protein immunoglobulin derived proteins, compositions, methods and uses
10/01/2009	US20090249502 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; antibody or antigen-binding fragment thereof that specifically binds to a 193P1E1B protein; drug delivery
10/01/2009	US20090247733 Novel Bone Mineralization Proteins, DNA, Vectors, Expression Systems
10/01/2009	US20090247609 Sm-protein based secretion engineering
10/01/2009	US20090247422 In SITU Induced Antigen Technology (ISIAT) for Identification of Polynucleotides Expressed during Infection or Colonization
10/01/2009	US20090246867 Glial mitogenic factors, their preparation and use
10/01/2009	US20090246855 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
10/01/2009	US20090246852 Therapeutic use of anti-cs1 antibodies
10/01/2009	US20090246793 Cudr as biomarker for cancer progression and therapeutic response
10/01/2009	US20090246228 Moraxella catarrhalis Proteins
10/01/2009	US20090246217 Novel Peptides for Treating and Preventing Immune-Related Disorders, Including Treating and Preventing Infection by Modulating Innate Immunity
10/01/2009	US20090246210 IL-1Beta Binding Antibodies and Binding Fragments thereof
10/01/2009	US20090246205 Inhibition of macrophage-stimulating protein receptor (ron)
10/01/2009	US20090246204 Use of a cd28 binding substance for making a pharmaceutical composition
10/01/2009	US20090246202 Human Endokine Alpha and Methods of Use
10/01/2009	US20090246201 Substances
10/01/2009	US20090246200 Anthrax carbohydrates, synthesis and uses thereof
10/01/2009	US20090246194 ERYTHROPOIETIN ANALOG-IgG FUSION PROTEINS
10/01/2009	US20090246192 1D05 PCSK9 antagonists
10/01/2009	US20090246191 Preparation of Purified Covalently Cross-linked Abeta Oligomers and Uses Thereof

1 ... 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 ... 1494